BamSEC and AlphaSense Join Forces
Learn More

Akcea Therapeutics, Inc. – Material Contracts

Material Contracts Filter

EX-10.4
from 8-K 7 pages Terms of Consulting Agreement
12/34/56
EX-10.3
from 8-K 9 pages Separation Agreement
12/34/56
EX-10.2
from 8-K 8 pages Akcea Therapeutics, Inc. July 9, 2020
12/34/56
EX-10.1
from 8-K 1 page Material contract
12/34/56
EX-10.2
from 8-K 8 pages Akcea Therapeutics, Inc. May 18, 2020
12/34/56
EX-10.1
from 8-K 2 pages April 24, 2020 Michael Price 22 Boston Wharf Road, 9th Floor Boston, Ma 02210 Dear Michael,
12/34/56
EX-10.4
from 10-Q 10 pages Terms of Strategic Advisory Services Agreement
12/34/56
EX-10.3
from 10-Q ~5 pages Non-Employee Director Compensation Plan
12/34/56
EX-10.1
from 8-K 8 pages Akcea Therapeutics, Inc. May 23, 2019
12/34/56
EX-10.1
from 8-K 9 pages Separation Agreement
12/34/56
EX-10.3
from 8-K 22 pages Akcea Therapeutics, Inc. 2015 Equity Incentive Plan Global Option Agreement
12/34/56
EX-10.2
from 8-K 8 pages Akcea Therapeutics, Inc. March 16, 2020
12/34/56
EX-10.1
from 8-K 5 pages March 16, 2020 Louis St. L. O’dea Akcea Therapeutics, Inc. 22 Boston Wharf Road, 9th Floor Boston, Ma 02210 Dear Louis,
12/34/56
EX-10.2
from 8-K 8 pages Akcea Therapeutics, Inc. December 13, 2018
12/34/56
EX-10.1
from 8-K 1 page March 5, 2020 Joshua Patterson Vice President, Legal Akcea Therapeutics, Inc. 22 Boston Wharf Road, 9th Floor Boston, Ma 02210 Dear Josh, It Is My Pleasure to Offer You an Appointment to General Counsel, Akcea Therapeutics, Inc. (“Akcea”). With This Change, You Will Also Be Invited to Join and Actively Participate in the Critical Aspects of the Decisions Made by Akcea’s Executive Council
12/34/56
EX-10.1
from 8-K 24 pages Akcea Therapeutics, Inc. 2015 Equity Incentive Plan Adopted by the Board of Directors: December 16, 2015 Approved by the Stockholders: December 16, 2015 Amended by the Board of Directors: July 15, 2016 Approved by the Stockholders: July 15, 2016 Amended by the Board of Directors: May 2, 2017 Approved by the Stockholders: June 19, 2017 Amended by the Board of Directors: December 5, 2017 Approved by the Stockholders: April 17, 2018 Amended by the Board of Directors: September 28, 2018 Approved by the Stockholders: November 21, 2018 Amended by the Board of Directors: December 13, 2019 Approved by the Stockholders: March 2, 2020 Termination Date: December 15, 2025
12/34/56
EX-10.15
from 10-K 85 pages License Agreement by and Between Akcea Therapeutics, Inc. and Pfizer Inc
12/34/56
EX-10.4
from 10-K ~5 pages Non-Employee Director Compensation Plan
12/34/56
EX-10.2
from 8-K 8 pages Akcea Therapeutics, Inc. December 2, 2019
12/34/56
EX-10.1
from 8-K 2 pages November 8, 2019 Alex Howarth 22 Boston Wharf Road, 9th Floor Boston, Ma 02210 Dear Alex,
12/34/56